A qualified health claim links a food or supplement to reduced disease risk using evidence that falls short of “significant scientific agreement,” so FDA allows it only with agency-specified qualifying language. FDA does not “approve” these claims. It issues a Letter of Enforcement Discretion saying it won’t object under specific conditions. Before you print or publish any such claim, pull the actual letter and copy its qualifying language exactly.
TL;DR:
- Using FDA-approved letters of enforcement discretion requires copying qualifying language exactly as issued, including serving size and disqualifying nutrient limits.
- The strength of qualifier wording varies based on evidence quality, with weaker evidence requiring longer, more hedged phrasing to avoid misleading consumers.
- A comprehensive compliance process includes verifying active letters, copying the exact language, documenting product compliance, and monitoring for updates or withdrawals of claims.
- Most brands should focus on governance and internal approval gates rather than petitioning for new claims, especially when existing letters suffice.
- Automated tools can help prevent claim drift across marketing channels by scanning content against FDA language and maintaining a clear audit trail.
Table of Contents
- What Are Qualified Health Claims, and How Do They Differ From Authorized Claims?
- How Does FDA Review Petitions and Issue Enforcement Discretion Letters?
- What Do Existing Qualified Health Claim Letters Look Like?
- How Do You Draft Qualifying Language Without Legal Risk?
- What’s the Compliance Checklist Before You Publish a Qualified Claim?
- How Should Brands Govern Qualified Health Claim Use Going Forward?
- How Does ScanCompliant Help Teams Manage Qualified Claim Risk?
- Sources
What Are Qualified Health Claims, and How Do They Differ From Authorized Claims?
An authorized health claim meets the “significant scientific agreement” (SSA) standard, the highest bar FDA sets for linking a food substance to reduced disease risk. A qualified health claim (QHC) rests on real but less conclusive evidence, so FDA requires qualifying language to keep the statement from misleading consumers. Think of it as a confidence rating attached to the claim itself.
The legal scaffolding runs through the Nutrition Labeling and Education Act, the FDA Modernization Act, and the regulatory text at 21 C.F.R. § 101.14, which spells out eligibility, validity standards, and disqualifying nutrient levels. FDA groups labeling claims into three buckets:
- Health claims (authorized and qualified), which describe a substance’s link to disease risk
- Nutrient content claims, which describe the level of a nutrient in a product
- Structure/function claims, which describe a role in normal body function without referencing disease
That third category matters because it sits outside the QHC framework entirely, and confusing the two is one of the more common labeling errors marketing teams make.
How Does FDA Review Petitions and Issue Enforcement Discretion Letters?
Getting a new qualified health claim onto the books runs through a formal petition process, not a simple application form. Here’s how it typically unfolds:
- A petition is submitted to FDA laying out the substance/disease relationship, supporting studies, and proposed claim wording.
- FDA dockets the petition and opens it for public comment, which anyone, including competitors, can weigh in on.
- The agency scores the evidence using its Evidence-Based Review System, ranking study quality, consistency, and biological plausibility.
- Weaker evidence gets stronger qualifiers. A claim backed by a handful of small trials gets phrases like “limited and not conclusive,” while stronger but still sub-SSA evidence might warrant softer hedging.
- FDA issues a Letter of Enforcement Discretion stating the exact claim language, required disclaimers, and the conditions (serving size, nutrient thresholds) under which it won’t pursue enforcement.
That letter is not a rulemaking action. It doesn’t amend statute or regulation; it’s a documented statement of enforcement intent, and any product meeting its conditions can rely on it, not just the original petitioner. Timelines vary widely. Some petitions may resolve relatively quickly, while others can take a longer time with back-and-forth from the agency before a letter issues, if one issues at all.
What Do Existing Qualified Health Claim Letters Look Like?
Reading actual letters teaches you more about qualifying language than any summary can. A few instructive examples:
- Green tea and cancer risk. FDA’s letter on green tea used notably cautious wording, reflecting evidence FDA considered weak, and the agency specified narrow conditions on which cancer types and which products could carry the claim.
- Yogurt and reduced risk of type 2 diabetes. This more recent letter permits a claim tied to regular yogurt consumption, with specific serving frequency and disqualifying nutrient limits baked into the qualifying text.
- Selenium and certain cancers. An older letter illustrates how FDA’s qualifying language has shifted over time as review standards evolved.
Qualifier strength varies enormously across these letters, from “may reduce the risk” to far more hedged constructions like “some scientific evidence suggests, but does not prove.” FDA maintains a public index of enforcement discretion letters covering every active QHC, and it’s searchable by substance and disease category. Check that index before assuming a claim you’ve seen on a competitor’s label is actually authorized for your product category.
How Do You Draft Qualifying Language Without Legal Risk?
The disclaimer is where most compliance failures happen, not the underlying ingredient transparency claim. FDA’s qualifying language has to be strong enough to prevent consumer confusion but not so heavy that it effectively cancels out the claim it’s attached to. Courts have pushed back on FDA-drafted disclaimers that did exactly that. Congressional Research Service analysis of Pearson v. Shalala found that First Amendment scrutiny applies when required disclaimers negate a claim rather than simply qualifying it, which is why FDA now calibrates disclaimer intensity to match the actual strength of the underlying evidence rather than defaulting to maximum caution.
Weak evidence gets longer, more hedged language. Moderate evidence gets shorter, more direct qualifiers. Matching tone to evidence strength is the whole exercise.
Pro Tip: Never rewrite a letter’s qualifying language “for clarity” or brand voice. Courts and FDA both treat the exact wording in the letter as the safe harbor. Paraphrasing, even with good intentions, forfeits the enforcement discretion protection entirely.
Practical drafting rules: keep the qualifier concise, avoid words that flatly negate the claim (“no evidence,” “unproven”), and preserve the claim’s core meaning rather than burying it under caveats. If you need help with tone calibration, our guide to misleading health claims walks through common disclaimer failures in DTC marketing copy.
What’s the Compliance Checklist Before You Publish a Qualified Claim?
Run through these steps every time a QHC touches packaging, a landing page, or an ad:
- Search FDA’s letter index by substance and disease to confirm an active letter exists for your exact claim.
- Read the full letter, not a summary, and copy the qualifying language verbatim, including serving size and frequency conditions.
- Check disqualifying nutrient levels under 21 C.F.R. § 101.14; a product too high in saturated fat, sodium, or cholesterol can lose eligibility even with a valid letter.
- Build an evidence packet documenting the letter, your product’s compliance with its conditions, and internal sign-off dates.
- If no letter exists, weigh a formal petition against simply avoiding the claim; petitions can take years and require real scientific investment.
- Monitor for changes. Letters can be withdrawn or revised as new evidence emerges, so someone on your team needs ownership of that watch list.
Regulatory teams that skip step four are the ones who struggle when FDA or FTC asks for justification later. A documented evidence packet and change log tied to each claim materially reduces exposure, especially at brands that update marketing copy frequently. Our playbook on documenting compliance decisions covers what that audit trail should actually contain.
How Should Brands Govern Qualified Health Claim Use Going Forward?
Most brands don’t need to petition FDA for a new claim. They need discipline in using the letters that already exist. Petitioning makes sense only when you have genuine differentiated science and years to invest.
Governance should include an approval gate before any QHC-adjacent copy ships, a named evidence owner responsible for each active claim, and an audit trail tied to letter conditions rather than internal memory. Where teams struggle is catching claim drift, when a compliant disclaimer on the label doesn’t survive the trip to a social post or an influencer script. That’s precisely where automated content scanning earns its place: catching qualifying language that quietly disappeared somewhere between legal review and the marketing calendar.
— Compliant Team
How Does ScanCompliant Help Teams Manage Qualified Claim Risk?
There are tools designed to address the gap between a compliant label and the many marketing channels that may repeat, shorten, or paraphrase that claim. Such platforms scan websites, social posts, and product listings against databases of risk terms, flagging language that drifts from FDA-specified qualifying wording before it goes live.
Teams typically run it as a pre-publish gate. Draft copy referencing a qualified health claim gets scanned, flagged findings get prioritized by risk level, and the plain-English explanations tell a marketer exactly why a phrase is a problem, not just that it is one. Every scan can leave a documented trail, the kind of evidence packet regulatory teams may need when FDA or FTC asks how a claim was reviewed. If your team is managing qualified claims across more than a handful of SKUs or channels, see how it fits your review process at Scancompliant with a free trial.
This article is general information, not a substitute for advice from a qualified lawyer. Consult a qualified legal professional about your own circumstances before acting on anything here.
Sources
- Qualified Health Claims | FDA
- Health Claims on Food and Dietary Supplement Labels: FDA Regulation and Select Legal Issues | CRS
- 21 C.F.R. § 101.14 Health claims: general requirements (CFR)